MC

Mehar Chand Nagpal

Director Director DIN 05285428
DIN 05285428 First appointment Jun 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Jun 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Mehar Chand Nagpal

Data last updated:

Mehar Chand Nagpal has 14 years in corporate governance. Formerly with 1 company, such as Multani Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 05285428
Primary Designation Director
First Appointment 01 Jun 2012
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Multani Pharmaceuticals Limited U24230DL1986PLC023539
Additional Director01 Jun 20121986₹274 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Multani Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Mehar Chand Nagpal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mehar Chand Nagpal

Mehar Chand Nagpal has 14 years in corporate governance. Formerly with 1 company, such as Multani Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Mehar Chand Nagpal has expertise in General Business.

Mehar Chand Nagpal has 14 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available